TransMedics Group, Inc.
TMDX · XNASCIK 1756262fmd_1BYJ444WHQBBQ9SXZA4Z8V5GB1Manufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Dec 31, 2016 to Sep 30, 2026, 36 periods
| Line item | FY2018 | FY2018 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 13 | 24 | – | 26 | 30 | 93 | 242 | 442 | 605 |
| Cost of revenue | – | 7 | 10 | 9 | – | 9 | 28 | 88 | 179 | 243 |
| Gross profit | – | 6 | 14 | 17 | – | 21 | 65 | 154 | 262 | 363 |
| Research and development | – | 14 | 20 | 19 | – | 22 | 27 | 36 | 56 | 69 |
| Selling, general and administrative | – | 12 | 24 | 24 | – | 38 | 70 | 120 | 169 | 185 |
| Total operating expenses | – | 26 | 43 | 43 | – | 61 | 97 | 183 | 225 | 254 |
| Operating income | – | (20) | (30) | (26) | – | (39) | (31) | (29) | 37 | 109 |
| Interest expense | – | 3 | 4 | 4 | – | 4 | 4 | 11 | 14 | 14 |
| Other non-operating income (expense) | – | (3) | (4) | (2) | – | (5) | (5) | 2 | (2) | (1) |
| Income before taxes | – | (24) | (34) | – | (29) | (44) | (36) | (27) | 36 | 108 |
| Income tax expense | – | 0 | 0 | – | 0 | – | 0 | (2) | 0 | (83) |
| Net income from continuing operations | – | (24) | (34) | – | (29) | – | (36) | (25) | 35 | 190 |
| Net income | (24) | – | (34) | – | (29) | (44) | (36) | (25) | 35 | 190 |
| Net income to common shareholders | – | – | – | – | – | – | – | (25) | 35 | 198 |